Citigroup Inc Viatris Inc Call Options Transaction History

Citigroup Inc

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 10, 2024	SELL	$11.27 - $13.53 $284,004 - $340,956	-25,200 Reduced 41.58%	35,400 $422,000
Q4 2023 Feb 09, 2024	BUY	$8.77 - $10.85 $180,662 - $223,510	20,600 Added 51.5%	60,600 $656,000
Q1 2023 May 11, 2023	BUY	$9.2 - $12.26 $368,000 - $490,400	40,000 New	40,000 $384,000
Q3 2022 Nov 10, 2022	SELL	$8.48 - $11.13 $42,400 - $55,650	-5,000 Reduced 12.5%	35,000 $298,000
Q2 2022 Aug 10, 2022	BUY	$9.95 - $12.27 $398,000 - $490,800	40,000 New	40,000 $419,000

1,102

934M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.8B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.